Adaptimmune Therapeutics (ADAP) Tops Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Adaptimmune Therapeutics (ADAP) Tops Q3 EPS by 2c

Adaptimmune Therapeutics (ADAP) will resume trading at 4:35pm ET

November 9, 2016 4:13 PM EST

Adaptimmune Therapeutics (NASDAQ: ADAP) will resume trading at 4:35pm EST.

... More

Adaptimmune Therapeutics (ADAP) Announces Lift of FDA Partial Clinical Hold on NY‑ESO SPEAR in MRCLS

November 9, 2016 4:06 PM EST

Adaptimmune Therapeutics plc (Nasdaq: ADAP) announced that the U.S. Food and Drug Administration has removed the partial clinical hold on the planned study of its NYESO SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell therapy in MRCLS.

Under a revised protocol,... More

Adaptimmune Therapeutics (ADAP), Novavax (NVAX) trading halted with news pending.

November 9, 2016 4:01 PM EST

Adaptimmune Therapeutics (NASDAQ: ADAP), Novavax (NASDAQ: NVAX) trading halted with news pending.

... More